As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

  3/7/24  Outlook Therapeutics, Inc.        8-K:5,9      3/7/24   11:234K                                   Toppan Merrill/FA        
  4/3/23  Outlook Therapeutics, Inc.        8-K/A:5,9   3/30/23   10:216K                                   Toppan Merrill/FA        
 3/30/23  Outlook Therapeutics, Inc.        8-K:5,9     3/29/23   11:538K                                   Toppan Merrill/FA        
 3/25/22  Outlook Therapeutics, Inc.        8-K:5       3/21/22   11:233K                                   Toppan Merrill/FA        
 3/26/21  Outlook Therapeutics, Inc.        8-K:1,5,9   3/24/21    5:563K                                   Toppan Merrill/FA        
 9/18/20  Outlook Therapeutics, Inc.        8-K:5,9     9/17/20    2:195K                                   Toppan Merrill/FA        
 3/24/20  Outlook Therapeutics, Inc.        8-K:1,3,5,9 3/19/20    2:51K                                    Toppan Merrill/FA        
 9/13/19  Outlook Therapeutics, Inc.        8-K:5,9     9/12/19    2:165K                                   Toppan Merrill/FA        
 9/24/18  Outlook Therapeutics, Inc.        8-K:5,9     9/21/18    2:175K                                   Toppan Vite NY Inc./FA   
 7/19/18  Outlook Therapeutics, Inc.        8-K:1,3,5,8 7/18/18    5:368K                                   Toppan Vite NY Inc./FA   
10/31/17  Outlook Therapeutics, Inc.        8-K:5,8,9  10/26/17    2:71K                                    Toppan Vite NY Inc./FA   

____________
¹	Filing/Form Type:
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.